Fig. 1
From: Tiliroside suppresses triple-negative breast cancer as a multifunctional CAXII inhibitor
Gene profile overview analysis of CAXII, and Kaplan–Meier survival curves of CAXII in TNBC. The expression of CAXII in breast cancer samples is significantly higher than of breast normal tissue (A, B) (P < 0.001). TNBC patients with a high expression level of CAXII had an inferior overall survival compared to those with a low level (P203963_at=0.0016, P204508_s_at=0.029, P204509_at=0.036, P210735_s_at=0.0073, Sample size: 392 in total) (C–F)